Baylon, Amanda A.
HRN: 16-66-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2023
CEFUROXIME 750MG (VIAL)
01/03/2023
01/09/2023
IVT
420
Q8
UTI; URTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractURTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes